版本:
中国

BRIEF-Akari Therapeutics says CEO Gur Roshwalb has been placed on administrative leave

May 11 Akari Therapeutics Plc

* Akari Therapeutics says Gur Roshwalb, CEO, has been placed on administrative leave - sec filing

* Akari Therapeutics says Ray Prudo in his role as executive chairman is temporarily assuming Roshwalb’S duties in his absence

* Akari Therapeutics - board has established ad hoc special committee to review involvement, if any, of co personnel with Edison investment research report Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐